Success Stories: EB-1A Approved for Ophthalmology Researcher Advancing Oculoplastics, Ophthalmic Imaging, and Glaucoma Diagnostics

 

Client’s Testimonial:

“I would like to sincerely thank you for your exceptional work and attention to detail throughout the preparation of my EB-1A petition over the past months. Your guidance, strategic approach, and responsiveness made the entire process much smoother and less stressful. I am thrilled with the approval of my EB-1A case without any RFE, which I know reflects the quality and thoroughness of your work. I truly appreciate the time and dedication you invested in understanding my background, organizing my evidence, and presenting my achievements in the strongest possible way.


On August 13th, 2025, we received another EB1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the field of Ophthalmology (Approval Notice).


General Field: Ophthalmology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: Brazil

State of Residence at the Time of Filing: Florida

Approval Notice Date: August 13th, 2025

Processing Time: 16 days (Premium Processing Requested)


Case Summary:     

North America Immigration Law Group (NAILG) framed this EB-1A case around a record that links precision diagnostics and evidence-based education to measurable improvements in patient care. The petition emphasized three pillars: modernizing medical education through precision-medicine frameworks; quantitative analysis of eyelid movement to improve the management of blepharospasm and hemifacial spasm; and investigating how intraocular pressure fluctuations affect microvasculature and retinal function to guide glaucoma treatment.

Research Focus and Contributions

  • Built and applied high-speed, quantitative blink-analysis methods to objectively track periocular movement disorders and treatment response.
  • Integrated imaging, electrophysiology, and stress-testing (e.g., Water Drinking Test) to map links among pressure spikes, vascular density, and ganglion-cell function in glaucoma.
  • Advanced precision-medicine approaches in medical education, connecting genomics, analytics, and clinical training to better patient outcomes.

Research Impact and Metrics

  • 43 journal articles (plus conference abstracts and a preprint).
  • 453 total citations, with multiple papers performing in the top percentiles for their publication years.
  • At least 15 completed reviews for international journals (with additional editorial leadership experience).

Here is an anonymized excerpt from a recommendation letter that underscores the practical impact of his work:

“[Client] introduced an objective, high-speed video system for analyzing eyelid movement, reducing reliance on subjective exams and enabling automated, clinician-friendly diagnostics. Using light-emitting markers to quantify blink amplitude, frequency, and closure velocity in blepharospasm and hemifacial spasm, the work demonstrated slower, weaker movements in affected patients. These results established an evidence-based, patient-specific framework for treatment planning and advanced neuro-ophthalmic care.”

Demonstrating Extraordinary Ability

We satisfied EB-1A criteria by documenting sustained service, judging the work of others through repeated journal reviews and senior editorial leadership, and authorship in selective venues with objective indicators of influence (extensive independent citation, top-percentile performance, invited talks). Together with a national-level award recognizing excellence in the field, these factors established standing among the small percentage at the top of ophthalmology.

Well Positioned for Continued Innovation

The record demonstrates advanced training, including an MD and a PhD in Ophthalmology and Visual Sciences, along with a sustained publication and citation trajectory and ongoing research integrating imaging, analytics, and clinical tools. These achievements provide clear evidence of the capacity to continue translating methods into diagnostics and care pathways with broad U.S. benefit. Independent expert testimonials and international uptake of the work further confirm forward momentum.

Approval and Outcome

Approved in just 16 days, this EB-1A success reflects the compelling evidence of extraordinary ability and national benefit. NAILG is proud to have guided this petition and looks forward to the client’s continued contributions to data-driven diagnostics and precision therapy development in ophthalmology.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.


approval_table_2017

Approval Notices: https://www.wegreened.com/eb1_niw_approvals

Success Stories: https://www.wegreened.com/blog/

Website: www.wegreened.com

Free evaluation: https://www.wegreened.com/Free-Evaluation

Tel: 888.666.0969 (Toll Free)


To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE


Copyright © North America Immigration Law GroupWeGreened.com, All Rights Reserved.